(Q80103667)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16906585%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

title

Variations in the detection of ZAP-70 in chronic lymphocytic leukemia: Comparison with IgV(H) mutation analysis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16906585%20AND%20SRC:MED&resulttype=core&format=json

chronic lymphocytic leukemia

28 December 2019

main subject

1 reference

Sheikholeslami MR

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16906585%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Jilani I

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16906585%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Keating M

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16906585%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Uyeji J

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16906585%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Chen K

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16906585%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Kantarjian H

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16906585%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

O'Brien S

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16906585%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Giles F

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16906585%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Albitar M

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16906585%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

publication date

1 July 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16906585%20AND%20SRC:MED&resulttype=core&format=json

Cytometry Part B: Clinical Cytometry

28 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16906585%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

volume

70

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16906585%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16906585%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

page(s)

270-275

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16906585%20AND%20SRC:MED&resulttype=core&format=json

Biology and treatment of chronic lymphocytic leukemia

28 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20134

7 January 2021

Perspectives on the use of new diagnostic tools in the treatment of chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20134

7 January 2021

Chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20134

7 January 2021

Genetics of chronic lymphocytic leukemia: genomic aberrations and V(H) gene mutation status in pathogenesis and clinical course

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20134

7 January 2021

ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20134

7 January 2021

ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20134

7 January 2021

ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20134

7 January 2021

ZAP-70 expression and prognosis in chronic lymphocytic leukaemia

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20134

7 January 2021

Expression of ZAP-70 is associated with increased B-cell receptor signaling in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20134

7 January 2021

Additional genetic high-risk features such as 11q deletion, 17p deletion, and V3-21 usage characterize discordance of ZAP-70 and VH mutation status in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20134

7 January 2021

Free circulating soluble CD52 as a tumor marker in chronic lymphocytic leukemia and its implication in therapy with anti-CD52 antibodies

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20134

7 January 2021

The LPL/ADAM29 expression ratio is a novel prognosis indicator in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20134

7 January 2021

High expression of lipoprotein lipase in poor risk B-cell chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20134

7 January 2021

Identifiers

DOI

10.1002/CYTO.B.20134

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16906585%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

1 reference